Chongqing Lummy Pharmaceutical - Asset Resilience Ratio

Latest as of March 2024: -0.19%

Chongqing Lummy Pharmaceutical (300006) has an Asset Resilience Ratio of -0.19% as of March 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥-5.53 Million

≈ $-809.13K USD Cash + Short-term Investments

Total Assets

CN¥2.98 Billion

≈ $435.55 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2007–2022)

This chart shows how Chongqing Lummy Pharmaceutical's Asset Resilience Ratio has changed over time. Check asset allocation strategy of Chongqing Lummy Pharmaceutical to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Chongqing Lummy Pharmaceutical's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 300006 market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥-5.53 Million	-0.19%
Total Liquid Assets	CN¥-5.53 Million	-0.19%

Asset Resilience Insights

Limited Liquidity: Chongqing Lummy Pharmaceutical maintains only -0.19% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Chongqing Lummy Pharmaceutical Industry Peers by Asset Resilience Ratio

Compare Chongqing Lummy Pharmaceutical's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Roche Holding AG SW:RO	Drug Manufacturers - General	15.37%
AstraZeneca PLC NYSE:AZN	Drug Manufacturers - General	0.10%
Dimed S.A. Distribuidora de Medicamentos SA:PNVL3	Drug Manufacturers - General	7.83%
Firebrick Pharma Ltd AU:FRE	Drug Manufacturers - General	0.29%
Eli Lilly and Company SA:LILY34	Drug Manufacturers - General	8.63%
Pfizer Inc SA:PFIZ34	Drug Manufacturers - General	5.48%
Zhangzhou Pientzehuang Pharmaceutical Co Ltd SHG:600436	Drug Manufacturers - General	17.40%
Sichuan Kelun Pharmaceutical Co Ltd SHE:002422	Drug Manufacturers - General	4.41%

Annual Asset Resilience Ratio for Chongqing Lummy Pharmaceutical (2007–2022)

The table below shows the annual Asset Resilience Ratio data for Chongqing Lummy Pharmaceutical.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2022-12-31	-0.29%	CN¥-8.78 Million ≈ $-1.29 Million	CN¥3.05 Billion ≈ $447.04 Million	-0.09pp
2021-12-31	-0.20%	CN¥-5.87 Million ≈ $-858.97K	CN¥2.93 Billion ≈ $428.28 Million	+0.15pp
2020-12-31	-0.35%	CN¥-11.00 Million ≈ $-1.61 Million	CN¥3.15 Billion ≈ $460.62 Million	-0.01pp
2019-12-31	-0.34%	CN¥-11.81 Million ≈ $-1.73 Million	CN¥3.50 Billion ≈ $512.37 Million	+0.03pp
2018-12-31	-0.37%	CN¥-11.68 Million ≈ $-1.71 Million	CN¥3.14 Billion ≈ $459.59 Million	-0.42pp
2013-12-31	0.05%	CN¥1.10 Million ≈ $160.96K	CN¥2.18 Billion ≈ $319.31 Million	-0.10pp
2010-12-31	0.15%	CN¥1.33 Million ≈ $195.32K	CN¥884.01 Million ≈ $129.36 Million	-0.04pp
2009-12-31	0.19%	CN¥1.27 Million ≈ $185.50K	CN¥653.63 Million ≈ $95.65 Million	-0.27pp
2008-12-31	0.46%	CN¥1.23 Million ≈ $180.46K	CN¥268.56 Million ≈ $39.30 Million	-0.19pp
2007-12-31	0.65%	CN¥1.40 Million ≈ $204.86K	CN¥214.69 Million ≈ $31.42 Million	--

pp = percentage points

About Chongqing Lummy Pharmaceutical

SHE:300006 China Drug Manufacturers - General

Market Cap

$784.93 Million

CN¥5.36 Billion CNY

Market Cap Rank

#9914 Global

#2559 in China

Share Price

CN¥5.08

Change (1 day)

+2.83%

52-Week Range

CN¥4.25 - CN¥6.58

All Time High

CN¥11.34